Barchart.com
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Biovaxys Technology Corp (BVAXF)

Biovaxys Technology Corp (BVAXF)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.0358 -0.0033 (-8.44%) 04/04/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.0358 unch (unch) 15:54 ET
Quote Overview for Fri, Apr 4th, 2025
Notes
Alerts
Watch
    Add or delete the symbol from one or more Watchlists.
  • Create New Watchlist
    This name already in use.
Help
Go To:
Day Low
0.0323
Day High
0.0368
Open 0.0323
Previous Close 0.0391 0.0391
Volume 449,700 449,700
Avg Vol 133,420 133,420
Stochastic %K 48.36% 48.36%
Weighted Alpha -55.22 -55.22
5-Day Change -0.0030 (-7.73%) -0.0030 (-7.73%)
52-Week Range 0.0290 - 0.0634 0.0290 - 0.0634
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
 Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A
Free Barchart Webinars! Live educational sessions using site features to explore today's markets.
Get delivered to your inbox for FREE:
Sign Up.

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0302 +18.54%
on 03/05/25
Period Open: 0.0317
0.0432 -17.13%
on 03/31/25
+0.0041 (+12.93%)
since 03/04/25
3-Month
0.0290 +23.45%
on 03/04/25
Period Open: 0.0457
0.0480 -25.42%
on 01/10/25
-0.0099 (-21.66%)
since 01/03/25
52-Week
0.0290 +23.45%
on 03/04/25
Period Open: 0.0600
0.0634 -43.53%
on 04/10/24
-0.0242 (-40.33%)
since 04/04/24

Most Recent Stories

More News
BioVaxys Technology Corp. Granted Management Cease Trade Order Newswire.ca - Mon Mar 3, 5:19PM CST

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announces that, further to its news release dated February...

BVAXF : 0.0358 (-8.44%)
BIOV.CN : 0.0450 (unch)
BioVaxys Announces Application for Management Cease Trade Order Newswire.ca - Thu Feb 13, 7:31PM CST

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announces that as a result of delays in the completion of...

BVAXF : 0.0358 (-8.44%)
BIOV.CN : 0.0450 (unch)
How Advanced Drug Delivery is Revolutionizing Global Healthcare in 2025 BayStreet.ca - Thu Jan 16, 8:19AM CST

Issued on behalf of BioVaxys Technology Corp. VANCOUVER – USA News Group – How we deal with future spikes in disease cases and potential global pandemics is evolving rapidly. Not only is the...

BVAXF : 0.0358 (-8.44%)
SVRA : 2.85 (-1.72%)
BIOV.CN : 0.0450 (unch)
TMO : 437.91 (-6.83%)
VERV : 3.62 (-5.85%)
AQST : 2.71 (-5.57%)
BioVaxys Developing DPX to be the Carrier of Choice for mRNA Vaccines, a market projected to grow to USD$48,000,000,000 by 2030* Newswire.ca - Thu Jan 16, 6:00AM CST

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") highlights the potential for its DPX™ non-systemic...

BVAXF : 0.0358 (-8.44%)
BIOV.CN : 0.0450 (unch)
BioVaxys Technology Corp. to Present at the Emerging Growth Conference on Thursday January 16, 2025 Newswire.ca - Tue Jan 14, 7:00AM CST

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company"), a clinical-stage company developing a portfolio of...

BVAXF : 0.0358 (-8.44%)
BIOV.CN : 0.0450 (unch)
New Vaccine Technologies Lead the Charge as Global Immunization Efforts Evolve BayStreet.ca - Wed Dec 18, 2024

Issued on behalf of BioVaxys Technology Corp. VANCOUVER – USA News Group – According to the World Health...

PCVX : 31.60 (+3.40%)
BVAXF : 0.0358 (-8.44%)
BIOV.CN : 0.0450 (unch)
GILD : 107.25 (-4.57%)
GOVX : 1.0200 (-7.27%)
ARCT : 9.11 (-3.95%)
BioVaxys Secures GMP-Grade Lipid Supply for Production of DPX-Based Vaccines in Advance of Preclinical and Clinical Program Ramp-Up Newswire.ca - Tue Dec 17, 2024

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") is pleased to announce that in anticipation of...

BVAXF : 0.0358 (-8.44%)
BIOV.CN : 0.0450 (unch)
BioVaxys Shares New Data on its DPX™ Immune Educating Platform at Personalized Cancer Vaccine Summit Newswire.ca - Thu Dec 5, 2024

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the Company") presented a new study today at the Personalized Cancer...

BVAXF : 0.0358 (-8.44%)
BIOV.CN : 0.0450 (unch)
Can Emerging Agritech and Biotech Solutions Meet the World’s Food Security Demands? BayStreet.ca - Wed Nov 20, 2024

Issued on behalf of BioVaxys Technology Corp. VANCOUVER – USA News Group – Reception to recent US election results has been mixed within the agriculture sector, with enthusiasm from some and...

CALM : 92.29 (-0.73%)
BVAXF : 0.0358 (-8.44%)
CTVA : 55.79 (-8.99%)
ELAN : 9.15 (-5.86%)
BIOV.CN : 0.0450 (unch)
ZTS : 151.73 (-4.94%)
BIOVAXYS PARTNER SPAYVAC FOR WILDLIFE, INC., SCALES-UP VACCINE PRODUCTION CAPACITY Newswire.ca - Wed Nov 20, 2024

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys") and SpayVac for Wildlife, Inc. are pleased to jointly announce that...

BVAXF : 0.0358 (-8.44%)
BIOV.CN : 0.0450 (unch)
BioVaxys to Participate in the US Government Biomedical Advanced Research and Development Authority (BARDA) Rapid Response Partnership Vehicle (RRPV) Vaccine Development Consortium Newswire.ca - Tue Nov 5, 2024

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") is pleased to announce that it has been invited to and...

BVAXF : 0.0358 (-8.44%)
BIOV.CN : 0.0450 (unch)
BioVaxys' DPX Exhibits Superior Immune System Activation Compared to Aqueous and Emulsion-Based Antigen Delivery Systems Newswire.ca - Thu Oct 31, 2024

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") highlights studies showing that its novel immune...

BVAXF : 0.0358 (-8.44%)
BIOV.CN : 0.0450 (unch)
BioVaxys to Present at the Emerging Growth Conference on October 30th, 2024 Newswire.ca - Mon Oct 28, 2024

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") a clinical-stage company developing a portfolio of...

BVAXF : 0.0358 (-8.44%)
BIOV.CN : 0.0450 (unch)
BioVaxys Engages Dr. Rajkannan Rajagopalan as Vaccine Formulations Advisor Newswire.ca - Tue Oct 8, 2024

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") is pleased to announce that it has engaged Rajkannan Rajagopalan, PhD,...

BVAXF : 0.0358 (-8.44%)
BIOV.CN : 0.0450 (unch)
Analysts Predict Strong Growth for Cancer Vaccine Market: Key Biotech Stocks to Consider BayStreet.ca - Wed Sep 4, 2024

Issued on behalf of BioVaxys Technology Corp. VANCOUVER – USA News Group – Back in 2022, Nature published...

BIOV.CN : 0.0450 (unch)
BVAXF : 0.0358 (-8.44%)
BNTX : 88.05 (-4.30%)
CVAC : 2.59 (-8.80%)
VXRT : 0.3365 (-11.26%)
IBRX : 2.83 (-4.71%)
BioVaxys to Present New Data on its DPX Immune Educating Platform at Personalized Cancer Vaccine Summit Newswire.ca - Wed Sep 4, 2024

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the Company") is pleased to announce that it has been invited to...

BIOV.CN : 0.0450 (unch)
BVAXF : 0.0358 (-8.44%)
The Future of Medicine: Drug Delivery Innovations Leading a $700 Billion Market BayStreet.ca - Fri Aug 23, 2024

Issued on behalf of BioVaxys Technology Corp. VANCOUVER – USA News Group – In the field of medicine, many...

LEXX : 1.4100 (-7.84%)
BIOV.CN : 0.0450 (unch)
BVAXF : 0.0358 (-8.44%)
TFFP : 0.0650 (-60.05%)
DNTH : 16.12 (-5.01%)
AQST : 2.71 (-5.57%)
BioVaxys DPX-Based Vaccines Exhibit Robust Efficacy Across Multiple Infectious Diseases Newswire.ca - Thu Aug 22, 2024

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") highlights the potential of its novel lipid-in-oil...

BIOV.CN : 0.0450 (unch)
BVAXF : 0.0358 (-8.44%)
Sustainable Agriculture: The Growing Need for Biotech Innovations in the World's Food Supplies Newswire.ca - Mon Aug 19, 2024

/CNW/ -- USA News Group – How we take care of the planet, and the food we eat is rapidly shifting. Back in May, the World Economic Forum addressed how...

BIOV.CN : 0.0450 (unch)
BVAXF : 0.0358 (-8.44%)
ZTS : 151.73 (-4.94%)
CTVA : 55.79 (-8.99%)
BG : 73.20 (-6.39%)
BRFS : 3.28 (-5.48%)
Innovative Agritech Solutions Powering the Future of Sustainable Agriculture BayStreet.ca - Mon Aug 19, 2024

Issued on behalf of BioVaxys Technology Corp. VANCOUVER – USA News Group – How we take care of the planet,...

BIOV.CN : 0.0450 (unch)
BVAXF : 0.0358 (-8.44%)
ZTS : 151.73 (-4.94%)
CTVA : 55.79 (-8.99%)
BG : 73.20 (-6.39%)
BRFS : 3.28 (-5.48%)
BioVaxys to Participate in the US Government Biomedical Advanced Research and Development Authority (BARDA) Rapid Response Partnership Vehicle (RRPV) Vaccine Development Consortium Newswire.ca - Tue Nov 5, 2024

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") is pleased to announce that it has been invited to and...

BVAXF : 0.0358 (-8.44%)
BIOV.CN : 0.0450 (unch)
BioVaxys' DPX Exhibits Superior Immune System Activation Compared to Aqueous and Emulsion-Based Antigen Delivery Systems Newswire.ca - Thu Oct 31, 2024

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") highlights studies showing that its novel immune...

BVAXF : 0.0358 (-8.44%)
BIOV.CN : 0.0450 (unch)
BioVaxys to Present at the Emerging Growth Conference on October 30th, 2024 Newswire.ca - Mon Oct 28, 2024

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") a clinical-stage company developing a portfolio of...

BVAXF : 0.0358 (-8.44%)
BIOV.CN : 0.0450 (unch)
BioVaxys Engages Dr. Rajkannan Rajagopalan as Vaccine Formulations Advisor Newswire.ca - Tue Oct 8, 2024

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") is pleased to announce that it has engaged Rajkannan Rajagopalan, PhD,...

BVAXF : 0.0358 (-8.44%)
BIOV.CN : 0.0450 (unch)
Analysts Predict Strong Growth for Cancer Vaccine Market: Key Biotech Stocks to Consider BayStreet.ca - Wed Sep 4, 2024

Issued on behalf of BioVaxys Technology Corp. VANCOUVER – USA News Group – Back in 2022, Nature published...

BIOV.CN : 0.0450 (unch)
BVAXF : 0.0358 (-8.44%)
BNTX : 88.05 (-4.30%)
CVAC : 2.59 (-8.80%)
VXRT : 0.3365 (-11.26%)
IBRX : 2.83 (-4.71%)
BioVaxys to Present New Data on its DPX Immune Educating Platform at Personalized Cancer Vaccine Summit Newswire.ca - Wed Sep 4, 2024

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the Company") is pleased to announce that it has been invited to...

BIOV.CN : 0.0450 (unch)
BVAXF : 0.0358 (-8.44%)
The Future of Medicine: Drug Delivery Innovations Leading a $700 Billion Market BayStreet.ca - Fri Aug 23, 2024

Issued on behalf of BioVaxys Technology Corp. VANCOUVER – USA News Group – In the field of medicine, many...

LEXX : 1.4100 (-7.84%)
BIOV.CN : 0.0450 (unch)
BVAXF : 0.0358 (-8.44%)
TFFP : 0.0650 (-60.05%)
DNTH : 16.12 (-5.01%)
AQST : 2.71 (-5.57%)
BioVaxys DPX-Based Vaccines Exhibit Robust Efficacy Across Multiple Infectious Diseases Newswire.ca - Thu Aug 22, 2024

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") highlights the potential of its novel lipid-in-oil...

BIOV.CN : 0.0450 (unch)
BVAXF : 0.0358 (-8.44%)
Sustainable Agriculture: The Growing Need for Biotech Innovations in the World's Food Supplies Newswire.ca - Mon Aug 19, 2024

/CNW/ -- USA News Group – How we take care of the planet, and the food we eat is rapidly shifting. Back in May, the World Economic Forum addressed how...

BIOV.CN : 0.0450 (unch)
BVAXF : 0.0358 (-8.44%)
ZTS : 151.73 (-4.94%)
CTVA : 55.79 (-8.99%)
BG : 73.20 (-6.39%)
BRFS : 3.28 (-5.48%)
Innovative Agritech Solutions Powering the Future of Sustainable Agriculture BayStreet.ca - Mon Aug 19, 2024

Issued on behalf of BioVaxys Technology Corp. VANCOUVER – USA News Group – How we take care of the planet,...

BIOV.CN : 0.0450 (unch)
BVAXF : 0.0358 (-8.44%)
ZTS : 151.73 (-4.94%)
CTVA : 55.79 (-8.99%)
BG : 73.20 (-6.39%)
BRFS : 3.28 (-5.48%)
More news for this symbol

Key Turning Points

Daily
52-Week
3rd Resistance Point 0.0421
2nd Resistance Point 0.0395
1st Resistance Point 0.0376
Last Price 0.0358
1st Support Level 0.0331
2nd Support Level 0.0305
3rd Support Level 0.0286

See More

52-Week High 0.0634
Fibonacci 61.8% 0.0503
Fibonacci 50% 0.0462
Fibonacci 38.2% 0.0421
Last Price 0.0358
52-Week Low 0.0290

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades
Wed, Apr 09, 2025 5:00 PM UTC
Reserve Your Spot

Info When You Need It Most.

Barchart Premier is one of the most powerful tools in the investment world. Come see why so many subscribers love it — and try it risk-free for 30 days.

Start 30-Day Risk Free Trial